Since p53 interacts with mTOR signaling at multiple levels via the Tsc1-Tsc2 complex [20, 21], we aimed to analyze whether hyperactivated mTOR signaling with a loss of p53 may specify ACC. The gene discussed is MTOR; the disease is adrenal cortex carcinoma.